What Osteogenics does

Osteogenics Biomedical, Inc. is a privately held dental regenerative medicine company founded in 1996 and headquartered in Lubbock, Texas. It manufactures and distributes a comprehensive portfolio of products used by oral surgeons, periodontists, prosthodontists, and general dentists in implant and reconstructive dental procedures. The core catalog spans non-resorbable and resorbable barrier membranes (Cytoplast™ dPTFE and titanium-reinforced membranes with proprietary Regentex™ surface texturing), bone graft substitutes (allograft, porcine xenograft under the Zcore™ brand with 88-95% void space, and synthetic alloplasts), soft tissue grafts (Cytoplast MicroDerm™ acellular dermal matrix with micro-cuts), sutures (PTFE non-absorbable and absorbable), fixation and tenting systems (Pro-fix™), bone harvesting instruments, ridge preservation kits, and osseodensification instruments distributed in partnership with Versah.

The company's commercial model is sales-led and direct-to-practitioner: US customers purchase through an account-gated eCommerce storefront with same-day shipping, while international customers (120+ countries) are served via a global distributor network. Revenue is generated almost entirely from one-time product sales, supplemented by a high-margin clinical education business — Osteogenics co-hosts recurring multi-day, multi-CE-credit courses with KOL-led partners (Pikos Institute, gIDE, Urban Regeneration Institute) at price points ranging from $695 to $19,996 per attendee. Marketing is anchored on clinical literature, peer-reviewed studies, surgical video content, and tradeshow participation rather than consumer advertising. The company operates within the Envista family of dental companies and is led by founder and co-owner Chad Bartee.

Name

Osteogenics

Legal name

Osteogenics Biomedical, Inc.

Website

https://osteogenics.com

Company type

Private

Founded year

1996

Operating status

Operating

Headcount range

101–250 employees

Short description

Osteogenics Biomedical manufactures dental regenerative products — barrier membranes, bone graft substitutes, soft tissue grafts, sutures, and fixation systems — sold directly to dental professionals in the US and through distributors in 120+ countries, supplemented by KOL-led clinical education courses.

Ownership category

akta.pro rank

Headquarters

HQ city

Lubbock

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Revenue model

1. Medical Device and Biomaterial Sales: Osteogenics generates revenue through the sale of dental regenerative products including barrier membranes (dPTFE, collagen), bone graft substitutes (allograft, xenograft, alloplast), soft tissue grafts, sutures, fixation systems, and surgical instruments. Products are sold directly to dental professionals via eCommerce (US customers) and through international distributor network.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

Core offering

No information available in the provided input.

Product overview

Osteogenics Biomedical is a dental regenerative medicine company offering a comprehensive portfolio of products for oral surgery and implant dentistry. The product line centers on barrier membranes (Cytoplast™ dPTFE and titanium-reinforced membranes), bone graft substitutes (allograft, xenograft from porcine sources including Zcore™ products, and synthetic alloplast materials), and soft tissue augmentation materials (including Cytoplast MicroDerm™ acellular dermal matrix). Additional offerings include sutures (absorbable and non-absorbable PTFE), fixation and tenting systems, bone harvesting instruments, ridge preservation kits, surgical blades, textbooks, and osseodensification products through Versah partnership. The portfolio is organized around surgical procedures including ridge preservation, horizontal and vertical ridge augmentation, sinus elevation, soft tissue augmentation, and suturing.

Differentiator

Problem solved

Functional benefit

Brands

• Cytoplast: Product line including TXT-200 Non-Resorbable High-Density PTFE Membranes, Ti-250 and Ti-150 Titanium-Reinforced PTFE Membranes, and Non-Absorbable PTFE Sutures
• Zcore
• Cytoplast MicroDerm
• Pro-fix
• enCore

Quantifiable outcome

• Product availability rate of 99% to minimize back-orders
• +1 more outcomes

Named customers7 records

Segments3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Six partnerships are on record, tiered flagship and core.

• Nobel BiocareflagshipStrategic or Co-development Partner · 1 May 2026Nobel Biocare partnered with Osteogenics to present the 2026 Advanced Bone Grafting Symposium in Scottsdale, AZ. This is Osteogenics' flagship educational event featuring multiple KOL speakers covering topics like vertical ridge augmentation, GBR, sinus grafting, and osseodensification. Nobel Biocare is a leading dental implant company.
• VersahcoreStrategic or Co-development PartnerVersah is a key educational and distribution partner for osseodensification products. Osteogenics hosts and promotes Versah Osseodensification Training Courses and offers Versah products through their platform. Courses cover osseodensification techniques for sub-crestal sinus lifts, ridge expansion, and immediate implant placement.
• Pikos InstitutecoreStrategic or Co-development PartnerPikos Institute is a premier dental implant education partner. Osteogenics hosts Pikos courses including Mastering Implant Dentistry Fundamentals, Sinus Grafting, Soft Tissue Grafting, and Guided Full Arch Reconstruction. Dr. Michael Pikos is featured as a key opinion leader.
• gIDE InstitutecoreStrategic or Co-development PartnergIDE (Global Institute for Dental Education) is a partner for advanced implant dentistry training. Osteogenics sponsors gIDE Master Clinician programs and Advanced Tissue Regeneration courses taught by Dr. Sascha Jovanovic.
• Urban Regeneration InstitutecoreStrategic or Co-development PartnerLed by Dr. Istvan Urban, the Urban Regeneration Institute offers advanced bone and soft tissue regeneration courses. Osteogenics hosts these courses including the 3-Day Advanced Bone & Soft Tissue Course in Budapest, Hungary.
• Envista (Parent Company)coreOthersOsteogenics is part of the Envista family of companies. The CCP Declaration page references Envistaco.com compliance and transparency. Contact person Abby Adams is listed as an Envista employee handling symposium inquiries.

Scale indicators2 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Geistlich Pharma: Swiss-headquartered leader in dental bone regeneration (Bio-Oss xenograft) and barrier membranes (Bio-Gide). Directly comparable as a regenerative-only dental specialist with global distribution serving periodontists and oral surgeons.
• Botiss Biomaterials: German regenerative specialist offering bone grafts (cerabone, maxgraft), soft tissue grafts (mucoderm), and barrier membranes. Closely comparable product portfolio targeting periodontists and oral surgeons across Europe.
• LifeNet Health: Non-profit allograft tissue organization offering dental bone grafts and soft tissue grafts (DermACELL). Directly comparable in the allograft/acellular dermal matrix space that includes Cytoplast MicroDerm.
• RTI Surgical: Tissue-based implant manufacturer serving dental and other surgical specialties with allograft and xenograft bone graft substitutes. Overlaps with Osteogenics' bone graft franchise.
• NovaBone Products: Manufacturer of synthetic bone graft substitutes (calcium phosphosilicate) for dental and orthopedic applications. Currently featured as a promotional partner on Osteogenics' homepage, indicating close category overlap.
• Salvin Dental Specialties: Dental surgical product distributor and manufacturer specializing in bone grafting materials, membranes, sutures, and instrumentation for oral surgeons and periodontists — near-identical product breadth to Osteogenics.

Broad incumbents

• Dentsply Sirona: Largest pure-play dental equipment and consumables company with an implant and regenerative materials portfolio (Astra Tech, Ankylos). Broad incumbent that overlaps with Osteogenics' regenerative offerings as part of a much wider portfolio.
• Straumann Group: Global dental implant leader that has expanded into regenerative materials (botiss biomaterials acquired in 2021). Comparable customer base (implantologists, periodontists) and overlapping product categories in membranes and bone grafts.
• ZimVie (Zimmer Biomet Dental): Spun off from Zimmer Biomet, ZimVie sells dental implants plus regenerative products including bone grafts and membranes. Overlaps with Osteogenics in regenerative biomaterials and serves the same surgical specialists.
• Nobel Biocare: Premium dental implant company and Osteogenics' flagship educational symposium partner (2026 Advanced Bone Grafting Symposium). Overlaps in regenerative materials and serves an identical clinician base.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xfacebook.com/osteogenics
• YouTubeyoutube.com/c/OsteogenicsBiomedical
• Facebookfacebook.com/osteogenics
• LinkedInlinkedin.com/company/osteogenics-biomedical-inc-
• Instagraminstagram.com/osteogenics

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Osteogenics